ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 375
    RA May Not Confer Addition Risk of Osteoporosis in Male Patients – Results of Cohort Analysis and Literature Review
  • Abstract Number: 457
    RA Patients with Medicare Only Insurance Have Similar Clinical Outcomes As Patients with Private Insurance Despite Having Less Access to Biologics
  • Abstract Number: 2213
    RA-Associated Autoantibodies Promote Synovial Fibroblasts Migration and Adhesion through a Peptidylarginine Deiminases (PAD) Dependent Pathway
  • Abstract Number: 528
    RA33 Challenges the Paradigm of Autoantigen Selection in Rheumatoid Arthritis
  • Abstract Number: 484
    Race Plays a Role in Influencing the Modest Lipid Lowering Effects of Hydroxychloroquine in Patients with Rheumatoid Arthritis, Independent of Statin Use
  • Abstract Number: 401
    Racial and Ethnic Disparities in Depression Diagnosis and Treatment for Adolescents with SLE: Analysis of a National Medicaid Sample
  • Abstract Number: 1459
    Racial Comparisons of Children with Idiopathic Uveitis: Results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
  • Abstract Number: 2124
    Racial Disparities in Lupus Pregnancy
  • Abstract Number: 1423
    Racial Disparities in Pain and Function after Total Knee Arthroplasty in the United States: A Systematic Literature Review
  • Abstract Number: 2109
    Racial Disparities in the Risk of Hospitalized Severe Allopurinol Hypersensitivity Syndrome – a US Nationwide Study (2009-2011)
  • Abstract Number: 2253
    Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes Are Persisting
  • Abstract Number: 1279
    Racial Variation in Total Knee Replacement in a Diverse Community-Based Clinical Trial
  • Abstract Number: 1312
    Radiocarpal Cartilage Matrix Changes 3-Months after Anti-TNF Treatment for Rheumatoid Arthritis – Feasibility Study Using MR T1ρ� Imaging
  • Abstract Number: 340
    Radiographic Assessment of Hand Osteoarthritis – the Role of Oblique View Images
  • Abstract Number: 1731
    Radiographic Damage of Facet Joints and Vertebral Bodies in the Cervical Spine in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
  • Abstract Number: 462
    Radiographic Progression in Patients with Early Rheumatoid Arthritis Has Not Become Milder over the Past Decades
  • Abstract Number: 2054
    Randomized, Double-Blind, Phase 3 Study of Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis
  • Abstract Number: 16
    Rantes/CCL5 Selectively Induces MMP-1 and MMP-13 Production in Rheumatoid Arthritis Synovial Fibroblasts Via PKC-δ and JNK Pathways
  • Abstract Number: 1670
    Rapidity of Therapeutic Response of Biologics Compared to Methotrexate Monotherapy in Early RA: A Network Meta-Analysis
  • Abstract Number: 655
    Rasch Analysis of the Hospital Anxiety and Depression Scale in Psoriatic Arthritis: Results from the Presta Study.  
  • Abstract Number: 3161
    Rates of Hospitalization for Infection and Related Mortality By Race/Ethnicity and Sex Among Patients with End-Stage Renal Disease Due to Systemic Lupus Erythematosus
  • Abstract Number: 146
    Rates of Lipid Testing and Statin Prescription Filling Among U.S. Medicaid Recipients with SLE, 2007-2010
  • Abstract Number: 2971
    Raynaud Phenomenon Subjects with Abnormal Capillary Dilations Show a Risk Threshold Diameter Value for the Transition to the Capillaroscopic Early� Scleroderma Pattern: A Case Control Study
  • Abstract Number: 2294
    Re-Scoring the 2011 Fibromyalgia Survey Criteria to be a Better Surrogate for Pain Centralization
  • Abstract Number: 1323
    Reaching Consensus – Volumetric Joint Space Width Calculations in Finger Joints of Arthritis Patients
  • Abstract Number: 1513
    Reactivation of Hepatitis B-Infection in German Patients with Inflammatory Rheumatic Diseases Treated with Biologics – a Monocentric Analysis Involving 1107 Patients
  • Abstract Number: 1809
    Real Life Implementation of Lupus Nephritis Randomized Controlled Trials
  • Abstract Number: 2745
    Real World Evaluation of Patients with Rheumatoid Arthritis Initiating Tofacitinib Vs. Adalimumab and Etanercept
  • Abstract Number: 2880
    Real-World Impact of Anti-TNF Medication Use on Patient Reported Outcomes in a Prospective Cohort of Patients with Ankylosing Spondylitis
  • Abstract Number: 2610
    Real-World Use of Tocilizumab in Rheumatoid Arthritis Patients: Cardiovascular Risk, Concomitant Treatment, and Outcomes over 6 Months of Follow-up
  • Abstract Number: 2346
    Rebamipide Suppresses Monosodium Urate Crystal-Induced Interleukin-1b Production through Regulation of Oxidative Stress and Caspase-1 in THP-1 Cells
  • Abstract Number: 3101
    Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Sclerostin Are Related to Joint Destruction in Early Rheumatoid Arthritis Unrelated to Polymorphisms of the Genes
  • Abstract Number: 2133
    Receptor Protein Tyrosine Phosphatase Alpha Enhances Rheumatoid Synovial Fibroblast Signaling and Promotes Arthritis in Mice
  • Abstract Number: 1762
    Reciprocal Roles of Intestinal Microbiota in the Pathogenesis of Organ-Specific Autoimmune Diseases in a Lymphopenia-Induced Autoimmunity Mouse Model
  • Abstract Number: 1832
    Recurrence-Rate of Thrombotic Events in SLE Patients Negative for Antiphospholipid Antibodies
  • Abstract Number: 542
    Reduced Expression of Mir-204 in Early RA Promotes Inflammatory Pathways in Synovial Fibroblasts
  • Abstract Number: 1143
    Reduced Hydrogen Sulfide Synthesis in the Joint, a New Player in the Pathogenesis of Osteoarthritis
  • Abstract Number: 1439
    Reducing Gastric Ulcers in Patients with a History of Gastrointestinal (GI) Ulcers Who Require Long-Term High-Dose Non-Steroidal Anti-Inflammatory Drug (NSAID) Therapy
  • Abstract Number: 2703
    Reduction in Matrix Metalloproteinase-1 and -2 Secretion from Fibroblast-like Synoviocytes after Induction of Adipogenesis By a Natural Peroxisome Proliferator-Activated Receptor Gamma Ligand, Arterpilin-C
  • Abstract Number: 1281
    Reduction in Rural-Urban Disparity in Discharge Disposition to Home after Total Knee Arthroplasty in the U.S
  • Abstract Number: 2736
    Reduction of Disease Burden on Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in DMARD-Naïve Patients with Active, Severe, Progressive Rheumatoid Arthritis
  • Abstract Number: 2001
    Reduction of HLA Class II Expression and Beta-2-Glycoprotein I Presentation By Fluvastatin in Vitro and in Vivo: Possible Mechanism of Statin-Induced-Deprocoagulation in the Antiphospholipid Syndrome
  • Abstract Number: 322
    Reduction of Treatment Needed for Knee Osteoarthritis after Bariatric Surgery
  • Abstract Number: 362
    Reference Curves of Bone Parameters Obtained By High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Healthy Women from 20 to 85 Years Old
  • Abstract Number: 683
    Referral Strategies for the Early Diagnosis of Axial Spondyloarthritis- a Systematic Review
  • Abstract Number: 1229
    Regional Variation in Measured Detection of Ankylosing Spondylitis
  • Abstract Number: 3106
    Regulation of ASK1 Expression By microRNA-17 and Their Correlation with Rheumatoid Arthritis Pathogenesis
  • Abstract Number: 15
    Regulation of Neutrophil Extravasation By Interleukin-8-Induced Intravascular Reactive Oxygen Species Production during the Inflammatory Response
  • Abstract Number: 2569
    Regulation of SIRT1 Maybe a Perfect Strategy in Treatment of Rheumatoid Arthritis
  • Abstract Number: 1935
    Regulation of T Follicular Helper Cells in Systemic Lupus Erythematosus By E3 Ubiquitin Ligase Cbl-b
  • Abstract Number: 1123
    Regulatory B Cells Regulate Skin and Lung Fibrosis and Immunological Abnormalities in a Topoisomerase I and Complete Freund’s Adjuvant-Induced Scleroderma Model Via an Antigen-Specific Manner
  • Abstract Number: 2157
    Relapse Characteristics and Glucocorticoid Use in Patients with Biopsy-Proven Giant Cell Arteritis
  • Abstract Number: 1111
    Relapse of Lupus after B-Cell Depletion Therapy Is Associated with Loss of Apoptotic Cell Clearance and Elevated Type I Interferon Responses in Lupus Prone BXD2
  • Abstract Number: 895
    Relapses and Predictive Factors in Henoch-SchÖnlein Purpura. study of 417 Patients
  • Abstract Number: 317
    Relation of Incident Bisphosphonate Use to Trajectory of Joint-Space Width
  • Abstract Number: 2389
    Relation of Pronated Foot Posture to Risk of Worsening Knee Pain during Gait and Compartment-Specific Knee Cartilage Damage
  • Abstract Number: 2305
    Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease
  • Abstract Number: 941
    Relationship Between Colchine Plasma Level and Frequency of Familial Mediterranean Fever Attacks
  • Abstract Number: 1518
    Relationship Between Estimated Sodium and Potassium Intake with Blood Pressure and Inflammatory Markers in Patients with Rheumatoid Arthritis
  • Abstract Number: 170
    Relationship Between Finger Joint Cartilage Evaluated By Ultrasound and Clinical Characteristics in Rheumatoid Arthritis (RA)
  • Abstract Number: 2780
    Relationship Between Immunogenicity, Hypersensitivity Reactions and Skin Tests Against Infliximab, Etanercept and Adalimumab in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
  • Abstract Number: 2883
    Relationship Between Improvements in Fatigue and Signs & Symptoms of Active Psoriatic: Arthritis a Sub-Analysis of a Phase 3 Study with Secukinumab
  • Abstract Number: 2593
    Relationship Between Index of Activity Speed (Time Up and Go test) and Patient-Reported Outcome in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
  • Abstract Number: 1432
    Relationship Between Patient Reported Outcome Measures and Evoked Pain Measures in Knee Osteoarthritis
  • Abstract Number: 235
    Relationship Between Tissue Stress during Gait and Patterns of Urate Deposition and Bone Erosion in Gout: A Biomechanical Computational Modelling Study
  • Abstract Number: 345
    Relationship Between Total Hip BMD T-Score and Incidence of Nonvertebral Fracture with up to 8 Years of Denosumab Treatment
  • Abstract Number: 238
    Relationship Between Ultrasonographic Synovial Inflammation  and Ultrasonographic Urate Deposition Findings in Patients with Gout
  • Abstract Number: 1893
    Relationship Between Vitamin D Levels and Disease Activity in Patients with Systemic Sclerosis
  • Abstract Number: 418
    Relationship of Race, Ethnicity, and Outcomes in Pediatric Localized Scleroderma: Possible Differences in Disease Activity
  • Abstract Number: 2307
    Relationship of Sleep Quality and Fibromyalgia Outcomes in a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of Bedtime, Rapidly Absorbed, Sublingual Cyclobenzaprine (TNX-102 SL)
  • Abstract Number: 2868
    Relative Efficacy of Adalimumab Versus Secukinumab in Active Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
  • Abstract Number: 2961
    Reliability and Validity of the Total Joint Count and Swollen Joint Count in Early Diffuse Systemic Sclerosis
  • Abstract Number: 1726
    Reliability of Radiographic Assessment of Psoriatic Arthritis Mutilans
  • Abstract Number: 295
    Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index Among Dermatologists, Rheumatologists, and Neurologists
  • Abstract Number: 827
    Reliability of the Quantitative Assessment of Peripheral Blood Perfusion By Laser Speckle Contrast Analysis in a Systemic Sclerosis Cohort
  • Abstract Number: 1725
    Reliable Evaluation of Structural Lesions of the Sacroiliac Joints on MRI in Patients with Axial Spondyloarthritis That Is Comparable to Evaluation of Inflammation Despite Minimal Calibration
  • Abstract Number: 3222
    Repeated Administration of Dapirolizumab Pegol (DZP) Appears Safe and Well Tolerated in Patients with Systemic Lupus Erythematosus (SLE) and Is Accompanied By an Improvement in Disease Activity: Results from a Phase 1 Study
  • Abstract Number: 637
    Repeated B Lymphocyte Depletion Therapy with Rituximab in Sjögren’s Syndrome: A Single Center Experience
  • Abstract Number: 1656
    Repeated CD4+ T-Cell Depletion in Patients with Rheumatoid Arthritis over Multiple Cycles of Rituximab Treatment
  • Abstract Number: 2024
    Replacing Radiographic Sacroiliitis By Structural Lesions on MRI of the Sacroiliac Joints in Two Early Axial Spa Cohorts: What Is the Impact on the Classification of Patients According to the ASAS Axial Spa Criteria?
  • Abstract Number: 2410
    Report from the International Consortium of Health Outcome Measurement Hip and Knee Osteoarthritis Working Group: Consensus on an International Standard Set of Outcomes Measures for Patients with Hip or Knee Osteoarthritis.
  • Abstract Number: 727
    Repository Corticotropin Injection (H.P. Acthar® Gel) Attenuates Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus (SLE) Requiring Corticosteroids
  • Abstract Number: 2544
    Representing the Variability in Patients’ Preferences
  • Abstract Number: 203
    Rescue of Copa Syndrome Cellular Phenotype By Autophagy Modifying Drugs
  • Abstract Number: 2078
    Reserve Capacity: Explaining the Link Between Socioeconomic Status and Depression/Anxiety Among Patients with Systemic Lupus Erythematosus 
  • Abstract Number: 1140
    Resident Non-Classical Monocytes Are Critically Important for Tissue Destruction in Arthritis
  • Abstract Number: 2227
    Resident’s Guide to Pediatric Rheumatology Mobile App: Assessing Enablers and Barriers of Use through Qualitative Focus Groups
  • Abstract Number: 1264
    Residential Proximity to Highways, DNA Methylation and Systemic Lupus Erythematosus
  • Abstract Number: 151
    Residual Synovitis in Ultrasound (US) Is Associated with an Evolution Towards Rheumatoid Arthritis  (RA) in Patients with Inflammatory Polyarthralgia without ANTI-Citrulinated Antibodies (ACPA)
  • Abstract Number: 1544
    Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis
  • Abstract Number: 302
    Resource Utilization in a US Sample of Patients with Sporadic Inclusion Body Myositis
  • Abstract Number: 2308
    Responder Compared to Mean Change Analyses in a Fibromyalgia Phase 2b Clinical Study of Bedtime Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL)
  • Abstract Number: 2313
    Responder Rates and Numbers Needed to Treat Based on Clinically Meaningful Improvements in Patient Reported Outcomes (PROs) Including Health-Related Quality of Life (HRQoL) after Sarilumab Treatment during a Phase III Randomized Controlled Trial (RCT)
  • Abstract Number: 1753
    Response Gene to Complement-32 Promotes Plasma Cell Differentiation and Enhances Lupus-like Chronic Graft Versus Host Disease
  • Abstract Number: 1050
    Response to Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies
  • Abstract Number: 3239
    Response to Methotrexate Predicts Mortality in Rheumatoid Arthritis up to 30 Years
  • Abstract Number: 1089
    Responsiveness of Physical Activity Measures Following Exercise Intervention in Individulas after Total Knee Arthroplasty
  • Abstract Number: 959
    Results from the Childhood Arthritis and Rheumatology Research Alliance Systemic JIA Consensus Treatment Plans Pilot Study
  • Abstract Number: 2139
    Results of a Phase 1b/2a Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XmAb®5871 in Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 344
    Results of a Phase 2 Clinical Trial to Evaluate the Effects of Romosozumab in Japanese Women with Postmenopausal Osteoporosis
  • Abstract Number: 2125
    Rheumatic and Non-Rheumatic Autoimmune Diseases in SLE Offspring
  • Abstract Number: 2037
    Rheumatic Manifestations May be the First Clinical Presentation of Arterial Calcification Due to CD73 Deficiency
  • Abstract Number: 433
    Rheumatoid Arthritis (RA) Biologic Switching and Cycling in a Large US Managed Care Population
  • Abstract Number: 87
    Rheumatoid Arthritis (RA) Risk Gene CCR6 Polymorphism: Drug-Induced “Reversal” of ER Binding and the Expression of Inflammatory Mediators -Potential Molecular Mechanism Links Between Estrogen and RA
  • Abstract Number: 35
    Rheumatoid Arthritis As a Risk Factor for Cardiovascular Events Following Hospitalized Pneumonia; A Population-Based Cohort Study
  • Abstract Number: 1027
    Rheumatoid Arthritis Disease Activity Assessment Frequencies in Clinical Practices Do Not Support Treat-to-Target Care
  • Abstract Number: 1214
    Rheumatoid Arthritis in Female Spouses in the Agricultural Health Study: Associations with Pesticides and Other Farm Exposures
  • Abstract Number: 2574
    Rheumatoid Arthritis Leads to Altered Gene Expression in the Brain and Behavioral Changes in Mice
  • Abstract Number: 1933
    Rheumatoid Arthritis Patient T Cells Recognize Neutrophil Extracellular Traps
  • Abstract Number: 2630
    Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up
  • Abstract Number: 2592
    Rheumatoid Arthritis Patients with Many Autoantibodies Have Different Characteristics at Presentation Compared to Patients with Few Autoantibodies
  • Abstract Number: 2486
    Rheumatoid Arthritis Quality Measures – Automated Display of Care Gaps and Capture of Physician Decision Making at the Clinic Visit
  • Abstract Number: 2714
    Rheumatoid Arthritis Synovial Fibroblast Potentiates Mast Cell Degranulation and Migration Independent of Cell-to-Cell Contact
  • Abstract Number: 1590
    Rheumatoid Arthritis-Related Interstitial Lung Disease (RA-ILD): Methotrexate and the Extension of Lung Disease Are Associated to Prognosis
  • Abstract Number: 1607
    Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner
  • Abstract Number: 1658
    Rheumatoid Factor Status Affects the Efficacy of First Biological Treatment in RA
  • Abstract Number: 1551
    Rheumatoid Vasculitis: A Decline in the XXI Century
  • Abstract Number: 1266
    Rheumatologic Diagnoses, Characteristics and Needs of Somali Patients Referred to a Rheumatology Clinic Serving the Somali Population
  • Abstract Number: 184
    Rheumatologists and Musculoskeletal Ultrasound: Discrepancy Between Attitudes, Desire and Reality in Routine Practice in South East England
  • Abstract Number: 2269
    Rheumatologists Consider Patient Preferences and Costs When Choosing Treatments for Rheumatoid Arthritis (RA) Patients. a Cross-European Discrete Choice Experiment
  • Abstract Number: 2631
    Rheumatologists More Likely to Perform Tobacco Cessation Counselling in Uncontrolled Rheumatoid Arthritis Visits
  • Abstract Number: 129
    Rheumatologists’ Approaches to Diagnosis and Treatment of Depression
  • Abstract Number: 1195
    Rheumatology Nurse Advice Line in Singapore Tertiary Hospital – Pilot Study
  • Abstract Number: 1182
    Rheumatology Training Experience – European Survey Among Rheumatology Trainees & Newly Qualified Specialists
  • Abstract Number: 2267
    Rheumatology Work Force Planning in Western Countries – a Systematic Literature Review
  • Abstract Number: 212
    Rising Incidence and Prevalence of Gout in the Canadian General Population
  • Abstract Number: 2249
    Risk and Risk Perception of Knee Osteoarthritis in the US: Population-Based Study
  • Abstract Number: 2197
    Risk Factors for Adverse Pregnancy Outcome in First-Line Treated Pregnancies in Antiphospholip Antibodies-Positive Women According to Different Treatment Protocols: A Single Center Experience over 30 Years
  • Abstract Number: 1844
    Risk Factors for Complicated Pneumonia in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 868
    Risk Factors for Cytomegalovirus Reactivation in Patients with Antineutrophil Cytoplasmic Antibody -Associated Vasculitis
  • Abstract Number: 2940
    Risk Factors for Late-Onset Thrombosis in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 1359
    Risk Factors for the Development of Gout in HIV Patients: A Retrospective Study
  • Abstract Number: 616
    Risk Factors for the Exacerbation of Interstitial Lung Disease (ILD) after Administration of Biologic Dmards in RA Patients with Pre-Existing ILD
  • Abstract Number: 2051
    Risk for Lower Intestinal Perforations in RA Patients Treated with Tocilizumab in Comparison to Treatment with TNF Inhibitors, Rituximab, Abatacept or Conventional Synthetic Dmards
  • Abstract Number: 32
    Risk for Lung Cancer in RA and Different RA Phenotypes: Results from a Population-Based Case-Control Study
  • Abstract Number: 2141
    Risk of Cancer in Non-TNFi Biologics-Treated RA
  • Abstract Number: 1956
    Risk of Cerebrovascular Accident in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
  • Abstract Number: 31
    Risk of Chronic Obstructive Pulmonary Disease in Rheumatoid Arthritis: A Population Based Cohort Study
  • Abstract Number: 610
    Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Treated with Biologic Disease-Modifying Therapy Compared with Conventional Therapy
  • Abstract Number: 2244
    Risk of Incident Atrial Fibrillation in Gout
  • Abstract Number: 2367
    Risk of Malignancy in Dermatomyositis with Anti-CADM-140/ Melanoma Differentiation- Associated Gene 5 Autoantibody
  • Abstract Number: 1975
    Risk of Mortality of Patients with Giant Cell Arteritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 1507
    Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis Patients: The Frequency and Associated Disease Features
  • Abstract Number: 2232
    Risk of Osteoporotic Fractures with Use of Cyclooxygenase-2 Inhibitors
  • Abstract Number: 886
    Rituximab As a Cyclophosphimide Sparing Agent for Patients with Multi-Relapsing Antineutrophil Cytoplasmic Antibody Associated Small Vessel Vasculitis
  • Abstract Number: 567
    Rituximab Associated Late Onset Neutropenia – a Rheumatology Case Series and Review of the Literature
  • Abstract Number: 1569
    Rituximab Efficacy in the Treatment of Diffuse Interstitial Lung Disease Associated with Rheumatoid Arthritis
  • Abstract Number: 277
    Rituximab in Refractory Mixed Connective Tissue Disease: An Observational Study
  • Abstract Number: 2362
    Rituximab in the Treatment of Jo-1 Antibody-Associated Antisynthetase Syndrome: Anti-Ro52 Positivity As a Marker for Severity and Treatment Response
  • Abstract Number: 751
    Rituximab Induced Serum Sickness: A Systematic Review
  • Abstract Number: 615
    Rituximab Non Responders Fail to Down Regulated CD19 on Naive B Cells
  • Abstract Number: 3234
    Roadblocks Perceived By Canadian Dermatologists for Referring Patients with Suspected Psoriatic Arthritis
  • Abstract Number: 3032
    Role of Adenosine and Neutrophils in Inflammation Associated with Mutations in CECR1 Gene
  • Abstract Number: 1625
    Role of Macrophages in the Cardiovascular Disease Associated to Rheumatoid Arthritis: Effects of ANTI-CCPS in the Phenotypic Switching and the Insulin Signalling
  • Abstract Number: 3008
    Role of PTP4A1 Tyrosine Phosphatase in Systemic Sclerosis
  • Abstract Number: 1118
    Role of the Chemokine Receptor CXCR3 in the Function of Regulatory B Cells in Patients with SLE
  • Abstract Number: 20
    Role of the Epigenetic Regulator EZH2 in Proinflammatory Macrophage Polarization and Signaling in Rheumatoid Arthritis
  • Abstract Number: 1921
    Role of TLRs in the Abnormal Secretion of CXCL-4 By Plasmacytoid Dendritic Cells of Patients with Systemic Sclerosis
  • Abstract Number: 1769
    Role of Topical Administration of Peptidylarginine Deiminase  Inhibitors in Murine Lupus
  • Abstract Number: 2819
    Rorc Antagonism Inhibits IL-23-Dependent Aberrant Bone Formation in Vivo
  • Abstract Number: 591
    Rosuvastatin Improves Endothelial Function in Patients with Inflammatory Joint Diseases, Longitudinal Associations with Atherosclerosis and Arteriosclerosis
  • Abstract Number: 1644
    Routine Assessment of Patient Index Data 3 (RAPID3)-Defined Remission Is As Stringent As ACR/EULAR Boolean-Defined Remission in a Clinical Trial of Patients with Early Rheumatoid Arthritis Treated with Abatacept
  • Abstract Number: 657
    Routine Assessment of Patient Index Data 3 Score (RAPID3) and Psoriasis Quality of Life (PQoL-12) Assess Different Domains in Psoriasis (PsO) and Psoriatic Arthritis (PsA) Patients
  • Abstract Number: 1417
    Rural Residence Does Not Impact Total Ankle Arthroplasty Utilization and Outcomes
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology